Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Genuardi · SciRah

Researcher profile · Semantic Scholar

E. Genuardi

Share profile

E. Genuardi — researcher profile on SciRah

h-index: 17
Works: 119
Citations: 1,205

Most-cited papers

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.
D. Drandi, Lenka Kubiczkova-Besse, S. Ferrero, N. Dani +17 more
2015Journal of Molecular Diagnostics124 citations Open access
Semantic Scholar
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.
M. Ladetto, C. Lobetti‐Bodoni, B. Mantoan, M. Ceccarelli +21 more
2013Blood93 citations Open access
Semantic Scholar
Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival
S. Ferrero, M. Ladetto, D. Drandi, F. Cavallo +21 more
2014Leukemia89 citations Open access
Semantic Scholar
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia
D. Drandi, E. Genuardi, I. Dogliotti, M. Ferrante +17 more
2018Haematologica79 citations Open access
Semantic Scholar
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
M. D'Agostino, G. Zaccaria, B. Ziccheddu, E. Rustad +14 more
2020Clinical Cancer Research57 citations Open access
Semantic Scholar
Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
N. Bolli, E. Genuardi, B. Ziccheddu, M. Martello +2 more
2020Frontiers in Oncology51 citations Open access
Semantic Scholar
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders.
J. Stewart, J. Gazdová, N. Darzentas, D. Wren +30 more
2021Blood Advances47 citations
Semantic Scholar
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network
D. Drandi, M. Alcantara, I. Benmaad, Arian Söhlbrandt +23 more
2020HemaSphere44 citations Open access
Semantic Scholar
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice
S. Galimberti, E. Genuardi, F. Mazziotta, L. Iovino +5 more
2019Frontiers in Oncology44 citations Open access
Semantic Scholar
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing
S. Oliva, E. Genuardi, L. Paris, M. D'Agostino +21 more
2023EClinicalMedicine29 citations Open access
Semantic Scholar
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma
S. Ferrero, Daniele Grimaldi, E. Genuardi, D. Drandi +22 more
2022Blood29 citations Open access
Semantic Scholar
New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies
I. Dogliotti, D. Drandi, E. Genuardi, S. Ferrero
2018Journal of Clinical Medicine25 citations Open access
Semantic Scholar
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma
S. Ferrero, L. Monitillo, B. Mantoan, D. Barbero +15 more
2013Annals of Hematology21 citations
Semantic Scholar
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
B. Ziccheddu, Claudia Giannotta, M. D'Agostino, G. Bertuglia +14 more
2024Blood Cancer Journal19 citations Open access
Semantic Scholar
MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
M. Ferrante, D. Furlan, S. Zibellini, M. Borriero +17 more
2021Diagnostics18 citations Open access
Semantic Scholar
Minimal Residual Disease Evaluation By Multiparameter Flow Cytometry and Next Generation Sequencing in the Forte Trial for Newly Diagnosed Multiple Myeloma Patients
S. Oliva, E. Genuardi, A. Belotti, P. Frascione +21 more
2019Blood17 citations Open access
Semantic Scholar
Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma
C. Lobetti‐Bodoni, B. Mantoan, L. Monitillo, E. Genuardi +5 more
2013Therapeutic Advances in Hematology17 citations Open access
Semantic Scholar
Minimal residual disease (MRD) in non‐Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network
I. Della Starza, M. Cavalli, L. A. De Novi, E. Genuardi +18 more
2019Hematological Oncology14 citations
Semantic Scholar
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
S. Oliva, L. De Paoli, M. Ruggeri, S. Caltagirone +11 more
2021Annals of Hematology13 citations Open access
Semantic Scholar
Multiparameter flow cytometry (MFC) and next generation sequencing (NGS) for minimal residual disease (MRD) evaluation: Results of the FORTE trial in newly diagnosed multiple myeloma (MM).
S. Oliva, E. Genuardi, A. Belotti, P. Frascione +16 more
202013 citations
Semantic Scholar
Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte Trial
S. Oliva, E. Genuardi, M. Petrucci, M. D'Agostino +18 more
202012 citations
Semantic Scholar
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories
Glykeria Gkoliou, A. Agathangelidis, G. Karakatsoulis, C. Lalayanni +14 more
2023Frontiers in Oncology11 citations Open access
Semantic Scholar
Comprehensive Minimal Residual Disease (MRD) Analysis of the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial for Younger Patients with Mantle Cell Lymphoma: A Kinetic Model Ensures a More Refined Risk Stratification
S. Ferrero, Barbero Daniela, Mariella Lo Schirico, A. Evangelista +23 more
2018Blood11 citations
Semantic Scholar
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma
Antonio Matera, A. Marella, A. Maeda, M. da Via +14 more
2022International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial
G. Zaccaria, S. Ferrero, E. Hoster, R. Passera +25 more
2021Cancers10 citations Open access
Semantic Scholar
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data
M. Beccuti, E. Genuardi, Greta Romano, L. Monitillo +6 more
2017BMC Bioinformatics10 citations Open access
Semantic Scholar
Application of the Euro Clonality next‐generation sequencing‐based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial
E. Genuardi, Greta Romano, M. Beccuti, B. Alessandria +8 more
2021British Journal of Haematology9 citations Open access
Semantic Scholar
Comparison of two real‐time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real‐time quantitative polymerase chain reaction performance
I. Della Starza, M. Cavalli, I. Del Giudice, D. Barbero +13 more
2014Hematological Oncology9 citations
Semantic Scholar
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.
C. Lobetti‐Bodoni, D. Ferrero, E. Genuardi, R. Passera +21 more
2012Mechanisms of Ageing and Development9 citations Open access
Semantic Scholar
Ficoll‐hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis
E. Genuardi, D. Barbero, Irene Dogliotti, B. Mantoan +17 more
2018International Journal of Laboratory Hematology8 citations
Semantic Scholar
Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network
C. Mannu, A. Gazzola, E. Ciabatti, F. Fuligni +12 more
2016Leukemia and Lymphoma8 citations
Semantic Scholar
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes.
G. Zaccaria, S. Ferrero, S. Rosati, M. Ghislieri +16 more
2019JCO Clinical Cancer Informatics7 citations Open access
Semantic Scholar
Minimal Residual Disease in Indolent Lymphomas: A Critical Assessment
Daniele Grimaldi, E. Genuardi, M. Ferrante, S. Ferrero +1 more
2018Current Treatment Options in Oncology7 citations
Semantic Scholar
Direct-Acting Antiviral Agents in Hepatitis C-Associated Indolent Lymphomas.
Michele Merli, E. Genuardi, S. Zibellini, S. Rattotti +27 more
2026New England Journal of Medicine6 citations
Semantic Scholar
Long‐term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients
R. Tavarozzi, Simone Ferrero, A. Evangelista, E. Genuardi +27 more
2025HemaSphere6 citations Open access
Semantic Scholar
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial
M. Khouja, E. Genuardi, Simone Ferrero, A. Laqua +24 more
2025Leukemia6 citations Open access
Semantic Scholar
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.
A. Pulsoni, Simone Ferrero, M. Tosti, S. Luminari +44 more
2024The Lancet Haematology6 citations
Semantic Scholar
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma
E. Genuardi, P. Klous, B. Mantoan, D. Drandi +20 more
2021Hematological Oncology6 citations Open access
Semantic Scholar
A Comparative Analysis Of Next-Generation Sequencing and Real-Time Quantitative PCR For Minimal Residual Disease Detection In Follicular Lymphomas
C. Pott, L. Monitillo, E. Genuardi, B. Mantoan +5 more
20136 citations
Semantic Scholar
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial
S. Ragaini, A. Gallì, E. Genuardi, Martina Gandossini +26 more
2025Blood Advances5 citations Open access
Semantic Scholar
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
S. Ferrero, Daniele Grimaldi, E. Arrigoni, Mariapia Pironti +24 more
2023Blood Advances5 citations Open access
Semantic Scholar
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.
B. Ziccheddu, Claudia Giannotta, M. D'Agostino, G. Bertuglia +14 more
2023medRxiv4 citations Open access
Semantic Scholar
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma
I. Della Starza, L. A. De Novi, M. Cavalli, N. Novelli +21 more
2020Hematological Oncology4 citations
Semantic Scholar
Euroclonality-NGS DNA Capture Panel for Integrated Analysis of IG/TR Rearrangements, Translocations, Copy Number and Sequence Variation in Lymphoproliferative Disorders
P. Stewart, J. Gazdová, N. Darzentas, D. Wren +28 more
2019Blood4 citations Open access
Semantic Scholar
Targeted Locus Amplification (TLA): A Novel Next Generation Sequencing (NGS) Technology to Detect New Molecular Markers and Monitoring Minimal Residual Disease (MRD) in Mantle Cell and Follicular Lymphoma
E. Genuardi, P. Klous, D. Drandi, B. Mantoan +16 more
20174 citations
Semantic Scholar
OAB-055: Gain and amplification of 1q induce transcriptome deregulation and worsen the outcome of newly diagnosed Multiple Myeloma patients
M. D'Agostino, A. Belotti, E. Zamagni, D. Auclair +20 more
2021Clinical Lymphoma, Myeloma & Leukemia3 citations
Semantic Scholar
A Comprehensive and Systematic Analysis of Minimal Residual Disease (MRD) Monitoring in Follicular Lymphoma: Results from the Fondazione Italiana Linfomi (FIL) FOLL12 Trial
M. Ladetto, S. Ferrero, I. Del Giudice, S. Galimberti +28 more
2021Blood3 citations Open access
Semantic Scholar
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow‐up
P. Ghione, E. Genuardi, D. Rossi, D. Drandi +17 more
2018British Journal of Haematology3 citations Open access
Semantic Scholar
Distinct Immunogenetic Signatures in IgA Versus IgG Multiple Myeloma
Katerina Gemenetzi, A. Agathangelidis, A. Papalexandri, A. Medina +14 more
20163 citations
Semantic Scholar
Clonal hematopoiesis dynamics influences long‐term outcomes of follicular lymphoma: Results from FIL FOLL12 trial
N. Maher, Riccardo Moia, M. Almasri, L. Cividini +37 more
2026HemaSphere2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Ladetto×27
Invite
M. Ladetto — researcher profile on SciRah
D. Drandi×21
Invite
D. Drandi — researcher profile on SciRah
M. Boccadoro×18
Invite
M. Boccadoro — researcher profile on SciRah
B. Mantoan×17
Invite
B. Mantoan — researcher profile on SciRah

×16

Invite

S. Ferrero — researcher profile on SciRah

L. Monitillo×13

Invite

L. Monitillo — researcher profile on SciRah

Invite

D. Barbero — researcher profile on SciRah

S. Cortelazzo×12

Invite

S. Cortelazzo — researcher profile on SciRah

G. Zaccaria×11

Invite

G. Zaccaria — researcher profile on SciRah

Invite

E. Ciabatti — researcher profile on SciRah

Invite

P. Musto — researcher profile on SciRah

Invite

S. Oliva — researcher profile on SciRah